06.24.2026
Therapeutics
$2,872,156.00
30 months
Novel Anti-Fibrotics for Fibrostenotic Crohn's Disease
The goal of this project is to develop a small molecule, anti-fibrotic therapeutic that will change the standard of care in CD and that will improve the quality of life and outcomes of patients with CD.